Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana
(2017)
Journal Article
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administration of the drug in its liposomal formulation as a single injection is being promoted in a campaign to bring the leishmaniases under control. Understandi... Read More about Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana.